Ogbuagu is an associate professor of medicine and director of the HIV clinical trials program of the Yale AIDS Program, section of infectious diseases at the Yale School of Medicine in New Haven, Connecticut.
Phase II Study Shows Efficacy of 6-Month Regimen of Lenacapavir, Teropavimab, and Zinlirvimab for HIV
Onyema Ogbuagu, MBBCh, FACP, FIDSA discussed 96% virologic suppression with lenacapavir-based therapy, showing similar results to daily oral regimens.
Read More
HIV Vaccine Progress in the Context of a Decades-Long Struggle: What Are the Challenges?